Partner Liane Peterson was quoted in a Bloomberg Law article, “Rush for Generic Go-Ahead on Novel Drugs Roils Pharma Industry,” about the growth in the number of generic drugmakers seeking to bring competing versions of brand name products to market as quickly as possible.
Peterson said the trend has led to more smaller players jumping in to be first-filers on profitable drugs, which “would suggest the bigger players don’t want to share the market with anyone else.”
People
Related News
08 November 2024
In the News
Federico Goudie on Brazil as Key Market – 'It just happens that Miami is a smart place to be'
Foley & Lardner LLP partner Federico Goudie shared insight on the growing importance of Brazil to the U.S. legal market in Daily Business Review, identifying Miami as a key place to be for firms working with Brazilian clients and Latin American clients more broadly.
08 November 2024
In the News
Louis Lehot Assesses 2024 Election Result, Prospect of Tech Deal Resurgence
Foley & Lardner LLP partner Louis Lehot appeared across legal and business press to discuss the likelihood of a resurgence across capital markets, venture capital, and tech M&A following the results of the 2024 U.S. presidential election.
07 November 2024
In the News
James McKee on Amendment 3's Failed Passage – 'Florida still has a significant market'
Foley & Lardner LLP partner James McKee's assessment of the future of the cannabis industry in Florida following the failed passage of Amendment 3, a constitutional amendment that would have legalized recreational use of marijuana for adults, appeared across media outlets, including CBS News Miami, NBC 6 South Florida, NPR/WUSF, Orlando Sentinel, South Florida Sun Sentinel, and WMNF 88.5 FM.